Navigation Links
Miriam Hospital researcher awarded $2.9 million NIH grant to study impact of maternal smoking
Date:10/29/2013

(PROVIDENCE, R.I.) Laura Stroud, Ph.D., a researcher with The Miriam Hospital's Centers for Behavioral and Preventive Medicine, was recently awarded a 5-year, $2,885,481 grant from the National Institutes of Drug Abuse, part of the National Institutes of Health (NIH), to further her work on the physiological impact of maternal smoking on fetal development and behavior.

Funded through the NIH's premiere Research Project Grant (R01) program, Stroud's research involves the use of ultrasound technology to identify real-time, fetal markers of risk among women who smoke during their pregnancies. Her goal is to determine whether maternal smoking will influence trajectories of fetal behavior, stress response, and brain structures over pregnancy, and if it could also predict infant neurobehavioral deficits, such as attention and self regulation deficits.

Despite the warnings and known health risks, approximately one in five expectant moms in the U.S. continues to smoke during pregnancy. Studies have consistently found that prenatal cigarette smoke exposure is associated with increased rates of behavior problems, irritability, attention-deficit and hyperactivity disorder, the risk of conduct disorder, adolescent onset of drug dependence and the risk for criminal arrest in offspring.

"Although there have been pervasive sanctions against smoking during pregnancy, 13 to 30 percent of infants are born exposed," said Stroud. "Given continued high exposure rates and links to costly offspring outcomes, new and innovative approaches are needed to identify and protect high-risk children and help pregnant smokers quit."

Stroud's research group previously demonstrated effects of maternal smoking on attention and self regulation deficits and hyperarousal in infants.

As a next step, the researchers will use fetal ultrasound assessments to observe fetal behavior, response to mild stress (using a vibratory sound stimulus), and 3D assessment of fetal brain structures, followed by two infant neurobehavior and stress hormone (cortisol) reactivity assessments. Participants will include pregnant smokers and a control group of pregnant non-smokers.

Stroud said the findings could shed light on the real-time impact of maternal smoking during pregnancy, identify new pre-birth markers of risk that could improve clinical care for pregnant smokers and other high-risk pregnancies, pinpoint new therapeutic targets to protect exposed fetuses, and lead to the development of new and focused intervention efforts for pregnant smokers.

The principal affiliation of Laura Stroud, Ph.D., is The Miriam Hospital (a member hospital of the Lifespan health system in Rhode Island) and direct financial and infrastructure support for this project was received through the Lifespan Office of Research Administration. Stroud is also an associate professor of psychiatry and human behavior at The Warren Alpert Medical School of Brown University.


'/>"/>

Contact: Nancy Jean
njean@lifespan.org
Lifespan
Source:Eurekalert

Related medicine news :

1. Miriam researcher helps develop global hepatitis C recommendations for injection-drug users
2. Miriam study reveals financial benefits of a plant-based, Mediterranean diet
3. Miriam researchers urge physicians to ask younger men about erectile dysfunction symptoms
4. Hospital-based Point of Care Diagnostics: Products, Players and Outlook to 2017
5. The Mount Sinai Hospital First in the World to Offer Patients New FDA Approved Device for Severely Calcified Arteries
6. A New Imaging Efficiency Dashboard from Health Data Intelligence Shines the Spotlight on the Quality and Efficient Use of Outpatient Medical Imaging Tests at US Hospitals
7. NewYork-Presbyterian/Morgan Stanley Children's Hospital Physician Offers Tips for a Safe and Sweet Halloween
8. Barnes-Jewish Hospital Offering New FDA-approved Non-surgical Procedure for Mitral Valve Repair
9. Multicenter Study Led by Texas Children's Hospital & Baylor College of Medicine Finds Prenatal Diagnosis & Birth Location May Significantly Improve Neonatal HLHS Survival
10. Florida Hospital Teams Up with The Tampa Bay Lightning to Raise Awareness About Breast Cancer & The Pink Army
11. IU, Regenstrief initiative aims to decrease hospitalization of nursing home residents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... WhoHaha , a digital media company dedicated to creating and delivering female-centric, comedic content, ... series that uses humor to highlight ways to improve heart health and overall well-being. ... movement, which is designed to inspire all Americans to make small changes that add ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for patients with sleep apnea and TMJ disorders. These conditions are quite common ... Dr. Rassouli provides personalized care to reduce the risk of these consequences and ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative ... Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries from ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor ... global anti-obesity drugs market is expected to grow at a ... and CAGR of 38.7% in the second half of the forecast ... 32.8% from 2016 to 2027. The market is estimated at $1,058 ... 2027. ...
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
Breaking Medicine Technology: